Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 120 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 3164. Clear
Clear
Q2
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code, Alcohol and Drug Abuse
View → Q2
VENABLE LLP for SUTTER HEALTH
2nd Quarter (Apr 1 - June 30) 2026 · California · House · $80,000.00 income
Health Issues
View → Q2
MEHLMAN CONSULTING, INC. for AMERICAN MEDICAL ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $80,000.00 income
Immigration, Medicare/Medicaid
View → Q2
VAN SCOYOC ASSOCIATES for SURESCRIPTS
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $50,000.00 income
Health Issues
View → Q2
VAN SCOYOC ASSOCIATES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $80,000.00 income
Medicare/Medicaid, Pharmacy, Health Issues
View → Q2
AMERICAN SOCIETY OF ANESTHESIOLOGISTS for AMERICAN SOCIETY OF ANESTHESIOLOGISTS
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Veterans
View → Q2
AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY for AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Veterans, Education, Insurance, Medical/Disease Research/Clinical Labs
View → Q2
CAPITOL COUNSEL LLC for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA)
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View → Q2
HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) for HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Pharmacy, Health Issues
View → Q2
LOPER CONSULTING LLC for AMERICAN MEDICAL ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $40,000.00 income
Medicare/Medicaid, Health Issues
View → Q2
HEALTHCARE LEADERSHIP COUNCIL for HEALTHCARE LEADERSHIP COUNCIL
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid
View → Q2
INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE
2nd Quarter (Apr 1 - June 30) 2026 · Wisconsin · House · Senate
Pharmacy
View → Q2
MCDERMOTT WILL & SCHULTE LLP for SURESCRIPTS
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $30,000.00 income
Health Issues, Science/Technology, Medicare/Medicaid
View → Q1
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for AMERICAN PHARMACIES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $60,000.00 income
Pharmacy, Medicare/Medicaid, Defense
View → 1A
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View → Q1
WALGREEN COMPANY for WALGREEN COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Consumer Issues/Safety/Products, Taxation/Internal Revenue Code, Pharmacy
View → Q1
CENCORA, INC. for CENCORA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Health Issues, Taxation/Internal Revenue Code
View → Q1
MONUMENT ADVOCACY for CENCORA
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $30,000.00 income
Health Issues
View → Q1
NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Manufacturing
View → Q1
CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Consumer Issues/Safety/Products, Advertising, Pharmacy, Taxation/Internal Revenue Code
View → Q1
THE KROGER CO. for KROGER CO
1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate
Food Industry (safety, labeling, etc.), Taxation/Internal Revenue Code, Health Issues, Consumer Issues/Safety/Products
View → Q1
WALMART INC. for WALMART INC
1st Quarter (Jan 1 - Mar 31) 2026 · Arkansas · House · Senate
Labor Issues/Antitrust/Workplace, Veterans, Manufacturing, Food Industry (safety, labeling, etc.)
View → Q1
AVENUE SOLUTIONS for AMERICAN MEDICAL ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View → Q1
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Manufacturing
View → Q1
BALLARD SPAHR LLP for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $50,000.00 income
Medicare/Medicaid, Pharmacy
View →
Page 1 of 5 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem